Detalhe da pesquisa
1.
Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma.
Blood
; 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38728378
2.
GPRC5D-Targeted CAR T Cells for Myeloma.
N Engl J Med
; 387(13): 1196-1206, 2022 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36170501
3.
Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy.
Blood
; 141(7): 756-765, 2023 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36327160
4.
A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma.
Blood
; 142(7): 621-628, 2023 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37319432
5.
Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profile.
Br J Haematol
; 2024 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38735683
6.
Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients.
Eur Heart J
; 44(22): 2029-2042, 2023 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36939851
7.
The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantation.
Br J Haematol
; 203(5): 840-851, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37614192
8.
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation.
N Engl J Med
; 382(9): 822-834, 2020 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32101664
9.
Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study.
Blood
; 137(11): 1527-1537, 2021 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512409
10.
Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients.
Haematologica
; 108(11): 3058-3067, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345467
11.
Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: Emphasizing the need for a consensus approach.
Am J Hematol
; 98(3): 421-431, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588413
12.
A prospective study of dysgeusia and related symptoms in patients with multiple myeloma after autologous hematopoietic cell transplantation.
Cancer
; 128(21): 3850-3859, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36041227
13.
Patient preferences for treatment in relapsed/refractory diffuse large B-cell lymphoma: a discrete choice experiment.
Future Oncol
; 18(25): 2791-2804, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35837970
14.
Presalvage International Staging System Stage and Other Important Outcome Associations in CD34+-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
Biol Blood Marrow Transplant
; 26(1): 58-65, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31493537
15.
Stem Cell Mobilization and Autograft Minimal Residual Disease Negativity with Novel Induction Regimens in Multiple Myeloma.
Biol Blood Marrow Transplant
; 26(8): 1394-1401, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32442725
16.
Prognostic Factors for Postrelapse Survival after ex Vivo CD34+-Selected (T Cell-Depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma.
Biol Blood Marrow Transplant
; 26(11): 2040-2046, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32712326
17.
Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma.
Cancer
; 126(23): 5077-5087, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32965680
18.
Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapy.
Br J Haematol
; 190(1): 45-51, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32135029
19.
Transplant strategies in relapsed/refractory Hodgkin lymphoma.
Blood
; 131(15): 1689-1697, 2018 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29500170
20.
Using genomic data for selecting the treatment of lymphoma patients.
Curr Opin Hematol
; 26(4): 303-312, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31107282